Topic
Active Surveillance
18 Podcasts • 2 Courses on BackTable
Hear how experienced physicians approach Active Surveillance on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 325 • 25 Aug 2026
Navigating the PSA Maze in Urology
Is an elevated prostate-specific antigen (PSA) the beginning or the end of the prostate cancer workup? On this episode of BackTable Urology, Dr. Ruchika Talwar interviews Dr. Tarik Benidir to explore the “PSA problem,” explaining why PSA is biologically useful but clinically imprecise, often leading to false positives, unnecessary biopsies, and detection of indolent disease. They discuss a rational, patient-centered approach to elevated PSA, including when to repeat the test, how to interpret results in the context of age, race, family history, and prostate size, and the use of PSA density and age-adjusted norms instead of rigid cutoffs.
This podcast is supported by
More on Active Surveillance
Loading recent podcasts…
Urology # 325
Aug 24, 2026
with Dr. Tarik Benidir, Dr. Ruchika Talwar
Is an elevated prostate-specific antigen (PSA) the beginning or the end of the prostate cancer workup? On this episode...
1,400+ listens
Urology # 301
May 4, 2026
with Dr. Udit Singhal, Dr. Ruchika Talwar
Are biomarkers the missing link in personalized prostate cancer care? What is the practical role of biomarkers across...
1,500+ listens
Urology # 269
Oct 27, 2025
with Dr. Jason Hafron, Dr. Ruchika Talwar
We have relied on PSA for decades, but what’s next in precision screening for prostate cancer? In this episode of...
1,800+ listens
Urology # 259
Sep 8, 2025
with Dr. Parth Modi, Dr. Neeraj Agarwal, Dr. Tyler Seibert
Could ongoing trials redefine the management of oligometastatic and advanced prostate cancer? In this installment of...
2,000+ listens
Urology # 317
Jul 16, 2026
with Dr. George R. Schade, Dr. Tiwa Akinsola
Can focal therapy truly “thread the needle” between active surveillance and radical prostate cancer treatment? In this...
1,500+ listens
Urology # 288
Feb 2, 2026
with Dr. Claire de la Calle, Dr. Ruchika Talwar
When is active surveillance the right choice for intermediate-risk prostate cancer patients? In this episode of...
4,300+ listens
Tumor Board # 23
Sep 22, 2025
with Dr. Raquibul Hannan, Dr. Brandon Manley, Dr. Mark Ball, Dr. Rana McKay
Kidney cancer management is evolving. How are experts adapting? In this installment of BackTable Tumor Board, Dr....
Tumor Board # 21
Aug 18, 2025
with Dr. Parth Modi, Dr. Neeraj Agarwal, Dr. Tyler Seibert
Could ongoing trials redefine the management of oligometastatic and advanced prostate cancer? In this installment of...
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.